BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17372260)

  • 1. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.
    Severi G; Hayes VM; Padilla EJ; English DR; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):610-2. PubMed ID: 17372260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
    Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population.
    Wokołorczyk D; Gliniewicz B; Stojewski M; Sikorski A; Złowocka E; Debniak T; Jakubowska A; Górski B; van de Wetering T; Narod SA; Lubiński J; Cybulski C
    Eur J Cancer Prev; 2010 Mar; 19(2):167-71. PubMed ID: 19952762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rs1447295 at 8q24 is a risk variant for prostate cancer in Taiwanese men.
    Chen M; Huang YC; Ko IL; Yang S; Chang YH; Huang WJ; Chen YM
    Urology; 2009 Sep; 74(3):698-701. PubMed ID: 19428064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
    Cussenot O; Azzouzi AR; Bantsimba-Malanda G; Gaffory C; Mangin P; Cormier L; Fournier G; Valeri A; Jouffe L; Roupret M; Fromont G; Sibony M; Comperat E; Cancel-Tassin G
    Clin Cancer Res; 2008 Sep; 14(17):5635-9. PubMed ID: 18765558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
    Wang L; McDonnell SK; Slusser JP; Hebbring SJ; Cunningham JM; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2007 Apr; 67(7):2944-50. PubMed ID: 17409399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease.
    Hamano T; Matsui H; Sekine Y; Ohtake N; Nakata S; Suzuki K
    J Urol; 2010 Aug; 184(2):738-42. PubMed ID: 20639049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles.
    Helfand BT; Loeb S; Cashy J; Meeks JJ; Thaxton CS; Han M; Catalona WJ
    J Urol; 2008 Jun; 179(6):2197-201; discussion 2202. PubMed ID: 18423739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
    Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of chromosome 8q24 variants with prostate cancer risk in the Siberian region of Russia and meta-analysis].
    Os'kina NA; Boiarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
    Mol Biol (Mosk); 2012; 46(2):234-41. PubMed ID: 22670519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24.
    Suuriniemi M; Agalliu I; Schaid DJ; Johanneson B; McDonnell SK; Iwasaki L; Stanford JL; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):809-14. PubMed ID: 17416775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.
    Torniainen S; Hedelin M; Autio V; Rasinperä H; Bälter KA; Klint A; Bellocco R; Wiklund F; Stattin P; Ikonen T; Tammela TL; Schleutker J; Grönberg H; Järvelä I
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):956-61. PubMed ID: 17507622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival.
    Hayes VM; Severi G; Southey MC; Padilla EJ; English DR; Hopper JL; Giles GG; Sutherland RL
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1223-5. PubMed ID: 16775185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
    Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
    Hayes VM; Severi G; Eggleton SA; Padilla EJ; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):993-6. PubMed ID: 15824176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of MUC1 genetic variation on prostate cancer risk and survival.
    Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
    Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians.
    Oskina NA; Boyarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
    Urol Oncol; 2014 Jan; 32(1):37.e7-12. PubMed ID: 23628314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.